The global pediatric drugs and vaccines market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The major factor that is expected to boost the market growth includes an increase in the immunization programs by the government level, a rise in the R&D investment from government, and private players, and the growing success rate with mass vaccinations. Pediatric vaccines are those which are given to children to protect them from harmful diseases which can be infectious or non-infectious. Sometimes inactivated viruses are added in these vaccines as adjuvants. These inactivated viruses lose their ability to cause any disease. However, the addition makes the vaccine more powerful to make the body’s immune system prone to outside diseases. These vaccines help the support the body to produce antibodies against viruses. In this way, vaccines support children develop a protective shield against harmful viruses. The availability of vaccines saves approximately 2 to 3 million lives per year. 

Immunization programs by the government acts to restrain the spread of dangerous viruses. Government programs conducted for vaccination supports children whose family lacks health insurance or can’t afford the vaccination programs. In the US, the Centers for Medicare and Medicaid Services (CMS) provide the funding to the Center for Disease Control (CDC) for such drives. Thus, the rising vaccination drives is regarded as the most important drivers for the global pediatric drugs and vaccine market. Further, there is an increasing spread of several viruses such as SARS, MERS, Corona, Plague, and Yellow Virus, among others. The prevalence of diseases globally is making most people conscious. As a result, people are taking more vaccines to prevent harmful diseases. Infants are more prone with these diseases. Thus, the widespread increase in harmful viruses is another reason behind the increase in pediatric vaccine consumption. 

Market Coverage

• The market number available for – 2020-2027

• Base year- 2020

• Forecast period- 2021-2027

• Segment covered- 

o By Product

o By Disease Indication

• Regions covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

• Competitive Landscape: Sanofi S.A., GlaxoSmithKline plc., and Merck & Co., Inc., among others. 

Key questions addressed by the report

• What is the market growth rate?

• Which segment and region dominate the market in the base year?

• Which segment and region will project the fastest growth in the market?

• How has COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

• Who is the leader in the market?

• How are players addressing challenges to sustain growth?

• Where is the investment opportunity?

Global Pediatric Drugs and Vaccines Market Report by Segment

By Product

• Vaccines
• Drugs

By Disease Indication

• Infectious Disease
• Allergy and Respiratory
• Cancer
• CVD
• Diabetes
• Others

Global Pediatric Drugs and Vaccines Market Report by Region

North America       

• US

• Canada

Europe

• Germany

• UK

• France

• Spain

• Italy

• Rest of Europe

Asia-Pacific    

• China

• Japan

• India

• Rest of Asia-Pacific

Rest of the World

• Latin America

• Middle East and Africa